Actuate Therapeutics, Inc. Common stock

Form S-1 Actuate Therapeutics Inc For: 11 October By Investing.com
Investing.com Nigeria · 11 Oct 2026
Actuate Therapeutics to Issue 3.7M Warrants to Bios Partners and Kairos Venture Investments in Connection With Agreements Not to Sell Shares for Two Years After Stock Sale Closes
Moomoo · 06 Oct 2026
Actuate Therapeutics Registers 50 Million Shares for Public Offering at $0.819 Each
Kalkine Media · 06 Oct 2026
Actuate Therapeutics And 2 Other Promising Penny Stocks To Watch
Simply Wall Street · 02 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.